| Literature DB >> 32807858 |
Ulrika Asenbaum1, Richard Nolz2, Stefan B Puchner1, Tobias Schoster1, Lukas Baumann3, Julia Furtner1, Daniel Zimpfer4, Guenther Laufer4, Christian Loewe1, Sigrid E Sandner4.
Abstract
Perioperative stroke is a devastating complication after coronary artery bypass graft (CABG) surgery, with atherosclerosis of the ascending aorta as important risk factor. During surgical manipulation, detachment of plaques can lead to consecutive embolization into brain-supplying arteries. High-pitch computed tomography angiography (HP-CTA) represents a non-invasive imaging modality, which provides the opportunity for comprehensive imaging of the ascending aorta, including plaque detection and advanced characterization. In our present retrospective study on 719 individuals, who had undergone HP-CTA within 6 months prior to CABG, atherosclerotic disease of the ascending aorta was evaluated with respect to perioperative stroke rates. For image analysis, the ascending aorta was divided into a proximal and distal part, consisting of four segments, and evaluated for presence and distribution of calcified and mixed plaques. All patients with perioperative stroke presented with atherosclerotic disease of the ascending aorta. The stroke rate was significantly associated with the presence and extent of atherosclerotic disease. Patients burdened with mixed plaques presented with significantly higher perioperative stroke rates. This study demonstrates that HP-CTA allows accurate evaluation of plaque extent and composition in the ascending aorta, and therefore may improve risk stratification of stroke prior to CABG.Entities:
Mesh:
Year: 2020 PMID: 32807858 PMCID: PMC7431556 DOI: 10.1038/s41598-020-70830-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Patient characteristics.
| Overall (n = 719) | No perioperative stroke (n = 707) | Perioperative stroke (n = 12) | ||
|---|---|---|---|---|
| Sex, female | 132/719 (18.4%) | 126/707 (17.8%) | 6/12 (50.0%) | 0.012 |
| Age, years | 68.0 (60.3–74.4) | 68.1 (60.9–74.3) | 64.7 (61.9–72.8) | 0.530 |
| Height, cm | 173.0 (168.0–178.0) | 173.0 (168.0–178.0) | 166.5 (160.5–174.5) | 0.203 |
| Weight, kg | 82.0 (74.0–94.0) | 82.0 (74.0–94.0) | 79.0 (73.3–99.5) | 0.698 |
| BMI, kg/m2 | 28.0 (25.0–31.0) | 28.0 (25.0–31.0) | 28.0 (23.8–31.8) | 0.993 |
| Smoking history | 339/719 (47.1%) | 330/707 (46.7%) | 9/12 (75.0%) | 0.051 |
| Active smokers | 127/719 (17.7%) | 124/707 (17.5%) | 3/12 (25.0%) | 0.453 |
| Family history of coronary heart disease | 117/719 (16.3%) | 115/707 (16.3%) | 2/12 (16.7%) | 1.00 |
| Diabetes mellitus | 285/719 (39.7%) | 278/707 (39.3%) | 7/12 (58.3%) | 0.207 |
| IDDM | 107/719 (14.9%) | 104/707 (14.7%) | 3/12 (25.0%) | |
| Dyslipidemia | 565/719 (78.6%) | 556/707 (78.6%) | 9/12 (75.0%) | 0.727 |
| Renal insufficiency, mild to moderate | 96/719 (13.4%) | 91/707 (12.9%) | 5/12 (41.7%) | 0.014 |
| Dialysis | 14/719 (1.9%) | 10/707 (1.4%) | 4/12 (33.3%) | < 0.001 |
| Serum creatinine, mg/dl | 1.0 (0.85–1.2) | 1.0 (0.85–1.2) | 1.28 (0.83–3.05) | < 0.001 |
| Hypertension | 651/719 (90.5%) | 641/707 (90.7%) | 10/12 (83.3%) | 0.316 |
| Carotid stenosis and history of stroke | 71/719 (9.9%) | 69/707 (9.8%) | 2/12 (16.7%) | 0.336 |
| Asymptomatic carotid stenosis | 162/719 (22.5%) | 158/707 (22.3%) | 4/12 (33.3%) | 0.483 |
| PAOD | 135/719 (18.8%) | 131/707 (18.5%) | 4/12 (33.3%) | 0.253 |
| Chronic lung disease | 206/719 (28.7%) | 202/707 (28.6%) | 4/12 (33.3%) | 0.552 |
| Previous CABG | 12/719 (1.7%) | 11/707(1.6%) | 1/12 (8.3%) | 0.184 |
| Previous heart valve operation | 3/719 (0.4%) | 3/707 (0.4%) | 0/12 | 1.000 |
| Previous myocardial infarction | 378/719 (52.6%) | 369/707 (52.2%) | 9/12 (75.0%) | 0.117 |
| Ejection fraction, % | 55.0 (45.0–60.0) | 55.0 (45.0–60.0) | 60.0 (45.0–60.0) | 0.341 |
| Atrial arrhythmia | 95/719 (13.2%) | 94/707 (13.3%) | 1/12 (8.3%) | 1.000 |
| One-vessel | 21/719 (2.9%) | 21/707 (3.0%) | 0/12 | 0.513 |
| Two-vessel | 85/719 (11.8%) | 84/707 (11.9%) | 1/12 (8.3%) | |
| Three-vessel | 613/719 (85.3%) | 602/707 (85.1%) | 11/12 (91.7%) | |
| Elective | 457/719 (63.6%) | 450/707 (63.6%) | 7/12 (58.3%) | 0.796 |
| Urgent | 234/719 (32.5%) | 229/707 (32.4%) | 5/12 (41.7%) | |
| Emergency | 28/719 (3.9%) | 28/707 (4.0%) | 0/12 | |
cm, centimeter; kg, kilogram; BMI, body mass index; kg/m2, kilogram per square meter; NIDDM, non-insulin-dependent diabetes mellitus; IDDM, insulin-dependent diabetes mellitus; mg/dl, milligrams per deciliter; PAOD, peripheral artery occlusive disease, CABG, coronary artery bypass grafting, NYHA, New York Heart Association classification; p, no perioperative stroke versus perioperative stroke.
Technical details of dual-source computer tomography angiography.
| Acquisition parameters | |||
|---|---|---|---|
| Scanner type | Somatom defintion flasha | Somatom drivea | Somatom forcea |
| Tube voltage (refkV) | 120 | 110 | 80 |
| Tube current (refmAs, CD4D) | 116 | 140 | 194 |
| Collimation (mm) | 128 × 0.6 | 128 × 0.6 | 192 × 0.6 |
| Rotation time (s) | 0.28 | 0.28 | 0.25 |
| Pitch | 2.4 | 2.4 | 1.9 |
| Soft kernel | B31f. | I30f. | Bv40, Bv36 |
| Iteration | None | Admire strength 3 | Admire strength 3 |
refkV, reference kilovolt; refmAs, reference milliampere seconds; mm, millimeter; sec, seconds; ml, milliliter; kg, kilogram; kV, kilovolt; ml/sec, milliliter/second.
aSiemens healthineers.
Figure 1Segmentation of the ascending aorta. “Centerline” of the ascending aorta from the valvular level to the level of the left subclavian artery with the corresponding curved planar reformations (a). Allocation of the ascending aorta into a proximal section, extending from the level of the origin of the most distal coronary artery to the level of the origin of the pulmonary artery bifurcation, and a distal section extending from the pulmonary artery bifurcation to the origin of the brachiocephalic trunk (b). Sections were determined orthogonally to the course of the “centerline”. For segmentation (c), a straight line was drawn through the center of the ascending and corresponding descending aorta at the level of the pulmonary artery bifurcation: (1) the anterior segment covered the sectors 45° on both sides of this straight line in the ventral part of the ascending aorta; (2) the posterior segment included the sectors 45° on both sides in the dorsal part of the ascending aorta. Subsequently, the remaining quarters to the right and to the left of the straight line were termed the (3) right, and the (4) left segment.
Figure 2Plaque characterization. Plaque that consisted of exclusively calcified components (HU ≥ 130) was classified as calcified plaque (a). Plaques that consisted of calcified (HU ≥ 130) and non-calcified (HU < 130) components (b), as well as exclusively non-calcified components (c), were graded as mixed plaques.
Plaque burden per patient.
| Patients (n = 719) | ||||
|---|---|---|---|---|
| Any plaque number of patients (%) | Calcified plaque number of patients (%) | Mixed plaque number of patients (%) | ||
| Ascending aorta, overall | 159/719 (22.1%) | 142/719 (19.7%) | 34/719 (4.7%) | < 0.001 |
| Ascending aorta, proximal | 112/719 (15.6%) | 102/719 (14.2%) | 15/719 (2.1%) | < 0.001 |
| Ascending aorta, distal | 99/719 (13.8%) | 82/719 (11.4%) | 24/719 (3.3%) | < 0.001 |
| Mechanically stressed segments | 133/719 (18.5%) | 114/719 (15.9%) | 26/719 (3.6%) | < 0.001 |
Any plaque, patients with either calcified and/or mixed plaques; p, calcified plaque versus mixed plaque.
Plaque burden, composition, and distribution in patients with atherosclerotic disease of the ascending aorta.
| Patients with atherosclerotic disease in the ascending aorta (n = 159) | ||||
|---|---|---|---|---|
| Any plaque number of patients (%) | Calcified plaque number of patients (%) | Mixed plaque number of patients (%) | ||
| Anterior | 53/159 (33.3) | 43/159 (27.0) | 10/159 (6.3) | < 0.001 |
| Right | 18/159 (11.3) | 14/159 (8.8) | 4/159 (2.5) | |
| Left | 65/159 (40.9) | 60/159 (37.7) | 5/159 (3.2) | |
| Posterior | 28/159 (17.6) | 25/159 (15.7) | 3/159 (1.9) | |
| Anterior | 36/159 (22.6) | 24/159 (15.1) | 12/159 (7.5) | < 0.001 |
| Right | 27/159 (17.0) | 18/159 (11.3) | 9/159 (5.7) | |
| Left | 47/159 (29.5) | 39/159 (24.5) | 8/159 (5.0) | |
| Posterior | 62/159 (39.0) | 46/159 (28.9) | 16/159 (10.1) | |
| 1 | 80/159 (50.3) | 82/159 (51.6) | 20/159 (12.6) | < 0.001 |
| 2 | 40/159 (25.2) | 29/159 (18.2) | 9/159 (5.7) | |
| 3 | 17/159 (10.7) | 17/159 (10.7) | 0/159 | |
| 4 | 5/159 (3.2) | 3/159 (1.9) | 0/159 | |
| 5 | 5/159 (3.2) | 4/159 (2.5) | 2/159 (1.3) | |
| 6 | 7/159 (4.4) | 5/159 (3.2) | 2/159 (1.3) | |
| 7 | 2/159 (1.3) | 0/159 | 1/159 (0.6) | |
| 8 | 3/159 (1.9) | 2/159 (1.3) | 0/159 | |
| Total | = 336 segments | = 336 segments | ||
Any plaque, patients with either calcified and/or mixed plaques; p, calcified versus mixed plaque.